摘要
核酸甲基化是基因表观遗传学修饰的一种重要方式,也是肿瘤最常见的驱动性分子事件。检测核酸甲基化游离形式不但能够对肿瘤进行早期辅助诊断及预后判断,而且可避免传统肿瘤组织活检方法侵入性和肿瘤异质性等问题。本文将回溯游离核酸甲基化检测在肿瘤诊断中的应用现状,剖析游离核酸甲基化检测面临的挑战,并对其临床应用前景进行展望。
It is one of the most important forms of nucleic acid methylation in gene epigenetic modification and the most common driving molecular event in tumors.Detection of the free form nucleic acid can not only assist in early diagnosis and prognosis of tumors,but also avoid the problems of invasion and tumor heterogeneity caused by traditional tumor biopsy methods.In the present paper,the application status of free nucleic acid methylation detection in tumor diagnosis was reviewed,the challenges faced by free nucleic acid methylation detection were analyzed,and prospect of its clinical application was prospected.
作者
孙祖俊
李冬
Sun Zujun;Li Dong(Department of Clinical Laboratory,Tongji Hospital,School of Medicine,Tongji University,Shanghai 200065,China)
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2020年第7期707-711,共5页
Chinese Journal of Laboratory Medicine
基金
国家自然科学基金(81873975,81974314,81802084)
上海市卫生系统优秀学科带头人培养计划(2018BR31)
上海市自然科学基金(19ZR1448800)
上海市医学引导类项目(19411964800)
上海市同济医院临床研究培育项目(ITJ(ZD)1803,ITJ(ZD)1905,ITJ(QN)1905)。
关键词
肿瘤
甲基化
游离核酸
液体活组织检查
Neoplasms
Methylation
Cell-free nucleic acids
Liquid biopsy